WO2005042711A9 - Pain-associated gene pnpg1 - Google Patents
Pain-associated gene pnpg1 Download PDFInfo
- Publication number
- WO2005042711A9 WO2005042711A9 PCT/US2004/035934 US2004035934W WO2005042711A9 WO 2005042711 A9 WO2005042711 A9 WO 2005042711A9 US 2004035934 W US2004035934 W US 2004035934W WO 2005042711 A9 WO2005042711 A9 WO 2005042711A9
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- pnpg1
- pain
- associated gene
- gene
- gene pnpg1
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2842—Pain, e.g. neuropathic pain, psychogenic pain
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US51522403P | 2003-10-28 | 2003-10-28 | |
US60/515,224 | 2003-10-28 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2005042711A2 WO2005042711A2 (en) | 2005-05-12 |
WO2005042711A9 true WO2005042711A9 (en) | 2010-03-18 |
Family
ID=34549381
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2004/035934 WO2005042711A2 (en) | 2003-10-28 | 2004-10-28 | Pain-associated gene pnpg1 |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2005042711A2 (en) |
-
2004
- 2004-10-28 WO PCT/US2004/035934 patent/WO2005042711A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2005042711A2 (en) | 2005-05-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB0318428D0 (en) | Gene drivers | |
AU2003273640A1 (en) | Autism gene | |
AU2003294705A1 (en) | NtSM GENE | |
AU2003299467A1 (en) | Canine gene microarrays | |
WO2005042711A9 (en) | Pain-associated gene pnpg1 | |
AU2003277902A1 (en) | Acc gene | |
AU2003302040A1 (en) | Novel cancer-associated gene | |
AU2003205812A1 (en) | Amp assay | |
EP1766082B8 (en) | Cog47 protein and s100beta gene polymorphism | |
AU2003241762A1 (en) | Dna shuflling | |
EP1701949B8 (en) | Assay for entactogens | |
AU2003267384A1 (en) | Bhyd gene | |
GB0310457D0 (en) | Enzyme | |
AU2003900232A0 (en) | Assay for gene expression ii | |
AU2003900043A0 (en) | Assay for gene expression | |
AU2003241946A1 (en) | Novel acylase gene | |
AUPR983102A0 (en) | Assay for gene expression | |
AU2003904172A0 (en) | Assay | |
AU2003903691A0 (en) | Photobioreactor | |
AU2003904687A0 (en) | An assay | |
AU2003100006A4 (en) | Adcaster | |
AU2003100198A4 (en) | Colourband Browbands | |
AU2003100325A4 (en) | Freez-A-Cube | |
GB0326598D0 (en) | Gene | |
GB0313773D0 (en) | Gene |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase in: |
Ref country code: DE |
|
122 | Ep: pct app. not ent. europ. phase |